Yin-Ching Iris Chen, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 1 | 2024 | 1617 | 0.560 |
Why?
|
| Receptors, Dopamine | 4 | 2006 | 296 | 0.460 |
Why?
|
| Dopamine | 7 | 2006 | 1606 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2024 | 36418 | 0.300 |
Why?
|
| Tomography, Emission-Computed | 8 | 2004 | 1123 | 0.250 |
Why?
|
| Theobromine | 1 | 2005 | 14 | 0.250 |
Why?
|
| Microdialysis | 3 | 2005 | 161 | 0.240 |
Why?
|
| Brain | 16 | 2024 | 27097 | 0.240 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2005 | 108 | 0.240 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2005 | 128 | 0.230 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2005 | 485 | 0.230 |
Why?
|
| Ferric Compounds | 2 | 2005 | 378 | 0.220 |
Why?
|
| Brain Mapping | 8 | 2006 | 6635 | 0.220 |
Why?
|
| Rats | 18 | 2024 | 23713 | 0.200 |
Why?
|
| Electrodes | 1 | 2024 | 611 | 0.200 |
Why?
|
| Dopamine Uptake Inhibitors | 5 | 2005 | 297 | 0.190 |
Why?
|
| Behavior, Animal | 3 | 2004 | 1873 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2006 | 8164 | 0.160 |
Why?
|
| Cell Transplantation | 2 | 2002 | 472 | 0.150 |
Why?
|
| Cocaine | 5 | 2004 | 958 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 8 | 2006 | 2725 | 0.140 |
Why?
|
| Amphetamine | 5 | 2005 | 224 | 0.130 |
Why?
|
| Huntington Disease | 5 | 2003 | 1145 | 0.130 |
Why?
|
| Rhodopsin | 1 | 2015 | 203 | 0.120 |
Why?
|
| Eye Injuries | 1 | 2015 | 227 | 0.100 |
Why?
|
| Corpus Striatum | 4 | 2006 | 1235 | 0.100 |
Why?
|
| Dextroamphetamine | 2 | 2005 | 134 | 0.090 |
Why?
|
| Drug Interactions | 2 | 2005 | 1417 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2004 | 3770 | 0.090 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2003 | 122 | 0.090 |
Why?
|
| Retinal Diseases | 1 | 2015 | 705 | 0.080 |
Why?
|
| Trinucleotide Repeats | 2 | 2001 | 257 | 0.080 |
Why?
|
| Neurons | 4 | 2015 | 9435 | 0.080 |
Why?
|
| Dopamine Agents | 3 | 2004 | 189 | 0.080 |
Why?
|
| Animals | 22 | 2024 | 168083 | 0.070 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2004 | 89 | 0.070 |
Why?
|
| Oxidopamine | 4 | 2002 | 172 | 0.070 |
Why?
|
| Thalamus | 2 | 2006 | 1047 | 0.070 |
Why?
|
| Ischemia | 1 | 2015 | 1889 | 0.070 |
Why?
|
| Neostriatum | 3 | 2004 | 247 | 0.070 |
Why?
|
| Salicylamides | 1 | 2005 | 33 | 0.060 |
Why?
|
| Quinpirole | 1 | 2005 | 32 | 0.060 |
Why?
|
| Dopamine Agonists | 2 | 2005 | 352 | 0.060 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2005 | 49 | 0.060 |
Why?
|
| Neuroprotective Agents | 2 | 2003 | 956 | 0.060 |
Why?
|
| Dopamine Antagonists | 1 | 2005 | 288 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 265 | 0.060 |
Why?
|
| Contrast Media | 3 | 2015 | 5311 | 0.060 |
Why?
|
| Propionates | 1 | 2004 | 181 | 0.050 |
Why?
|
| Lactic Acid | 5 | 2004 | 1139 | 0.050 |
Why?
|
| Blood Volume | 1 | 2005 | 547 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 2 | 2000 | 25 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2006 | 4164 | 0.050 |
Why?
|
| Oxides | 1 | 2004 | 401 | 0.050 |
Why?
|
| Avian Proteins | 1 | 2002 | 79 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2004 | 285 | 0.050 |
Why?
|
| Adrenergic Agents | 2 | 2002 | 74 | 0.050 |
Why?
|
| Nicotine | 1 | 2006 | 678 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2001 | 375 | 0.040 |
Why?
|
| Basal Ganglia | 2 | 2000 | 554 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2004 | 301 | 0.040 |
Why?
|
| Motor Activity | 4 | 2004 | 2712 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2002 | 347 | 0.040 |
Why?
|
| Striatonigral Degeneration | 1 | 1999 | 13 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1997 | 240 | 0.040 |
Why?
|
| Riluzole | 1 | 1999 | 59 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2003 | 959 | 0.040 |
Why?
|
| Energy Metabolism | 5 | 2004 | 2877 | 0.040 |
Why?
|
| Oxygen | 3 | 2005 | 4226 | 0.040 |
Why?
|
| Encephalitis | 1 | 2002 | 439 | 0.040 |
Why?
|
| Iodoacetates | 1 | 1997 | 17 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1607 | 0.040 |
Why?
|
| Neural Pathways | 3 | 2006 | 3057 | 0.040 |
Why?
|
| Time Factors | 5 | 2005 | 39953 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2002 | 1172 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 446 | 0.030 |
Why?
|
| Iron | 1 | 2004 | 1790 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1668 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 3696 | 0.030 |
Why?
|
| Nerve Degeneration | 4 | 2003 | 747 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1999 | 603 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1999 | 486 | 0.030 |
Why?
|
| Glucose | 3 | 2004 | 4341 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2002 | 1984 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10755 | 0.030 |
Why?
|
| Microglia | 1 | 2002 | 1357 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2000 | 1007 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 1881 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2004 | 901 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1997 | 874 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 2003 | 561 | 0.020 |
Why?
|
| Sympatholytics | 2 | 2002 | 82 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2002 | 4008 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2015 | 941 | 0.020 |
Why?
|
| Parkinson Disease | 2 | 2002 | 2869 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4405 | 0.020 |
Why?
|
| Male | 17 | 2015 | 360675 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 1026 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 5777 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 1999 | 1085 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3512 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14676 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2004 | 73 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2004 | 366 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2006 | 629 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 2006 | 490 | 0.010 |
Why?
|
| Humans | 8 | 2024 | 761098 | 0.010 |
Why?
|
| Succinic Acid | 1 | 2004 | 86 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2004 | 348 | 0.010 |
Why?
|
| Choline | 1 | 2004 | 515 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3031 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 2003 | 393 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 415 | 0.010 |
Why?
|
| Gliosis | 1 | 2002 | 245 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 370 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 703 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2002 | 352 | 0.010 |
Why?
|
| Apomorphine | 1 | 2000 | 149 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2087 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 135 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 1535 | 0.010 |
Why?
|
| Toes | 1 | 2000 | 209 | 0.010 |
Why?
|
| Acupuncture Analgesia | 1 | 1999 | 63 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2262 | 0.010 |
Why?
|
| Saccades | 1 | 2000 | 234 | 0.010 |
Why?
|
| Acupuncture Points | 1 | 1999 | 111 | 0.010 |
Why?
|
| Chorea | 1 | 1999 | 79 | 0.010 |
Why?
|
| Rotation | 1 | 2000 | 517 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1633 | 0.010 |
Why?
|
| Models, Structural | 1 | 1998 | 338 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1997 | 11 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1997 | 44 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1033 | 0.010 |
Why?
|
| Fingers | 1 | 2000 | 506 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 77 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 1997 | 72 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1999 | 374 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1997 | 245 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22129 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1866 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1997 | 129 | 0.010 |
Why?
|
| Oxidative Stress | 2 | 1999 | 3114 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1999 | 495 | 0.010 |
Why?
|
| Neurochemistry | 1 | 1996 | 29 | 0.010 |
Why?
|
| Electron Transport Complex II | 1 | 1996 | 53 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6224 | 0.010 |
Why?
|
| Artifacts | 1 | 2004 | 1913 | 0.010 |
Why?
|
| Disease Progression | 2 | 2004 | 13506 | 0.010 |
Why?
|
| Spin Labels | 1 | 1997 | 337 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 2025 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1996 | 145 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 401 | 0.010 |
Why?
|
| Hand | 1 | 2000 | 902 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 1577 | 0.010 |
Why?
|
| Magnetics | 1 | 1998 | 598 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 3266 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1997 | 462 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 1662 | 0.010 |
Why?
|
| Female | 7 | 2003 | 392458 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1996 | 411 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 20120 | 0.010 |
Why?
|
| Glycolysis | 1 | 1998 | 836 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2000 | 2256 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1996 | 574 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1997 | 1498 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7240 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 4618 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2003 | 22157 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 1112 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 665 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1148 | 0.010 |
Why?
|
| Adult | 6 | 2003 | 221083 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1173 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 9317 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 81324 | 0.000 |
Why?
|
| Positron-Emission Tomography | 1 | 2004 | 6585 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11066 | 0.000 |
Why?
|
| Linear Models | 1 | 1998 | 5869 | 0.000 |
Why?
|
| Middle Aged | 4 | 2003 | 220835 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1999 | 8639 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4196 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 18217 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1997 | 8478 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15845 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 39121 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13630 | 0.000 |
Why?
|
| Aging | 1 | 1996 | 8701 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 64670 | 0.000 |
Why?
|